Ambuja Cements and 5 other stocks to buy for an upside of up to 59%

Ambuja Cements and 5 other stocks to buy for an upside of up to 59%

Synopsis: Brokerages have recommended six stocks, which are Kajaria Ceramics, Ambuja Cements, Akums Drugs, DCB Bank, Varun Beverages, and Arvind SmartSpaces, with “Buy” ratings with an upside potential ranging from about 24% to 59% from current levels.

The Benchmark Indices concluded Friday’s trading session negatively, with the Sensex decreasing by 367.25 points, or 0.43 percent, ending the day at 85,041.45. Meanwhile, the Nifty 50 index decreased by 99.80 points, or 0.38 percent, and closed in red at 26,042.30.

Below are six stocks that brokerages have recommended for a potential upside of up to 59 percent.

With a market capitalisation of Rs. 15,513 cr, the shares of Kajaria Ceramics Ltd closed at Rs. 974.05 per share, up from its previous close of Rs. 973.35 per share. Analysts at Emkay have assigned a “Buy” rating to Kajaria Ceramics Ltd with a target price of Rs. 1,550 per share, implying an upside potential of about 59% from Friday’s closing level.

Kajaria Ceramics is India’s largest manufacturer of ceramic and vitrified tiles, with a strong domestic distribution network and multiple manufacturing facilities across the country. The company focuses on premium products, innovation in designs, and brand-led growth while expanding its presence in value-added and export segments.

With a market capitalisation of Rs. 1,37,037 cr, the shares of Ambuja Cements Ltd closed at Rs. 554.40 per share, up from its previous close of Rs. 548.55 per share. Analysts at Motilal Oswal have assigned a “Buy” rating to Ambuja Cements Ltd with a target price of Rs. 750 per share, implying an upside potential of about 35% from Friday’s closing level.

Ambuja Cements is one of India’s leading cement manufacturers and a part of the Adani Group. It has a strong presence across India with integrated cement plants, grinding units, and a wide logistics network. The company focuses on cost efficiency, sustainability, and capacity expansion to strengthen its market position.

With a market capitalisation of Rs. 7,076 cr, the shares of Akums Drugs & Pharmaceuticals Ltd closed at Rs. 449.60 per share, up from its previous close of Rs. 446.55 per share. Analysts at ICICI Securities Ltd have assigned a “Buy” rating to Akums Drugs & Pharmaceuticals Ltd with a target price of Rs. 600 per share, implying an upside potential of about 34% from Friday’s closing level.

Akums Drugs & Pharmaceuticals is one of India’s largest contract development and manufacturing organizations (CDMOs), supplying formulations and APIs to domestic and global pharmaceutical companies. It operates across multiple therapeutic segments and is known for its strong R&D capabilities and wide manufacturing footprint.

With a market capitalisation of Rs. 5,481 cr, the shares of DCB Bank Ltd closed at Rs. 170.40 per share, down from its previous close of Rs. 173.55 per share. Analysts at Ventura have assigned a “Buy” rating to DCB Bank Ltd with a target price of Rs. 228 per share, implying an upside potential of about 34% from Friday’s closing level.

DCB Bank is a private sector bank in India offering retail, SME, and corporate banking services. It has a strong focus on secured lending, housing loans, and MSME finance, with improving asset quality and a growing digital banking presence supporting its long-term growth.

With a market capitalisation of Rs. 1,63,333 cr, the shares of Varun Beverages Ltd closed at Rs. 482.95 per share, up from its previous close of Rs. 477.70 per share. Analysts at Emkay have assigned a “Buy” rating to Varun Beverages Ltd with a target price of Rs. 615 per share, implying an upside potential of about 27% from Friday’s closing level.

Varun Beverages is one of the largest bottlers and distributors of PepsiCo beverages globally. The company has a strong presence in India and several international markets, with a diversified portfolio including carbonated drinks, juices, and packaged water, supported by expanding capacity and distribution reach.

With a market capitalisation of Rs. 2,742 cr, the shares of Arvind SmartSpaces Ltd closed at Rs. 598 per share, down from its previous close of Rs. 606.95 per share. Analysts at Axis Direct have assigned a “Buy” rating to Arvind SmartSpaces Ltd with a target price of Rs. 740 per share, implying an upside potential of about 24% from Friday’s closing level.

Arvind SmartSpaces is a real estate development company focused on residential and mixed-use projects, primarily in Gujarat and Bengaluru. It emphasizes asset-light development, premium housing, and joint development models to improve capital efficiency and project execution.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

  • Manideep is a financial analyst at Trade Brains with over 3+ years of experience in IPOs, equities, and company analysis. He has written 500+ articles and covered the Indian stock market’s opening and closing bells. In addition, he has strong knowledge in the commodity market and delivers actionable insights for investors.

Leave a Reply

Your email address will not be published. Required fields are marked *